Vanucizumab (Anti-Angiopoietin 2 & VEGF)

製品コード：A4064        

印刷

Vanucizumab is a humanized bispecific IgG1 antibody targeting VEGF-A and Ang-2 to inhibit tumor angiogenesis. It is being developed for the treatment of advanced solid tumors demonstrating anti-tumor, anti-angiogenic, and anti-metastatic effects. M.W 146.89 kDa

製品説明

CAS No. 1448221-05-3
Source CHO
Storage
(From the date of receipt)		 -80℃
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。